C

Cadrenal Therapeutics
D

CVKD

19.880
USD
0.38
(1.95%)
مغلق
حجم التداول
646
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
35,435,822
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Cadrenal Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.